Abstract submission open: 22 July 2022
Abstract submission deadline: 5 August 2015, 21:00 Central European time
(Download the Late-Breaking Abstracts as PDF)
Late-breaking abstracts describe the latest advances that will change our daily clinical practice. They should highlight novel and practice-changing studies. Focus is placed on capturing abstracts with ground-breaking and unique data that would not otherwise have been presented at the Congress.
Examples of suitable late-breaking abstracts might include the results of a practice-changing prospective Phase III clinical trial; a Phase II study showing anti-tumour activity in a novel context; an early clinical trial with novel proof-of-principle data, or the demonstration of novel cancer biology with therapeutic implications – in each case the results should not have been fully available by the regular abstract submission deadline.
Note: The late-breaking abstract deadline is not an extension of regular abstract submission deadline.
More details and Information: Policy and Regulation
PRINT THIS PAGE